Fluvoxamine: What Prescribers and Pharmacists Need to Know – Covid-19 Advisory for Ontario Related: Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence. RCT: Early treatment with fluvoxamine reduced the risk of emergency care and hospitalization among patients with COVID-19. [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and […]

The post Fluvoxamine for Covid-19: What Prescribers and Pharmacists Need to Know. appeared first on Links Medicus.